SQ
SQZ Biotechnologies Company
SQZB · OTC
$0.02 +0.00% (+$0.00)
1M +0.00%
Market Cap $707.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.03x
P/B 0.01x
P/E N/A
Growth
26 /100
Declining Rev. growth 1.50%
Book val. growth 0.83%
EPS growth N/A
Profitability
19 /100
Weak Gross margin 46.57%
FCF margin 399.79%
Net margin 377.88%
Quality
3 /100
Poor ROIC 81.66%
Asset turnover 0.20x
ROA 74.14%
Debt
91 /100
Low Debt/Equity 0.60x
Net debt/EBITDA 0.46x
Current ratio 3.12x
Stability
44 /100
Moderate Beta 0.32x
Profitable years 0
Rev. volatility 25.73%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SQZB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howard Bernstein
Employees
53
Headquarters
Watertown
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report